
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0488 | -3.08860759494 | 1.58 | 1.68 | 1.38 | 1638786 | 1.53736284 | CS |
4 | -1.7588 | -53.4589665653 | 3.29 | 3.49 | 1.26 | 3783841 | 2.07102949 | CS |
12 | -11.6488 | -88.3823975721 | 13.18 | 14.255 | 1.26 | 2532171 | 3.761727 | CS |
26 | -10.7788 | -87.5613322502 | 12.31 | 16.1 | 1.26 | 1386346 | 5.60236156 | CS |
52 | -13.8188 | -90.0247557003 | 15.35 | 16.52 | 1.26 | 920351 | 7.48105715 | CS |
156 | -6.8188 | -81.6622754491 | 8.35 | 36.64 | 1.26 | 805389 | 15.80245728 | CS |
260 | -20.9688 | -93.1946666667 | 22.5 | 43.92 | 1.26 | 551634 | 16.5513802 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.